Skip to main contentSkip to navigation
Print subscriptions
Newsletters
Sign in

AstraZeneca

January 2026

  • The company said it would spend the money by 2030 to expand medicines manufacturing and research and development in China.

    AstraZeneca to invest £11bn in China after rowing back on UK expansion

    Keir Starmer says the move, announced during his trip to Beijing, will help support thousands of British jobs

December 2025

  • Emma Walmsley

    US is the best place for drug companies to invest, says boss of London-based GSK

    Emma Walmsley’s praise for US pharmaceutical market piles pressure on UK government

November 2025

  • A female pharmacist at work in a chemist

    NHS won’t get cutting-edge drugs unless it pays more, says AstraZeneca boss

  • Nils Pratley

    Nils Pratley on finance
    Time for Reeves to recognise reality: AstraZeneca has killed stamp duty on shares

    Nils Pratley

September 2025

  • Nils Pratley

    Nils Pratley on finance
    AstraZeneca’s listing rejig spells long-term danger for London

    Nils Pratley
    It’s not skipping off entirely to New York, but pharma giant sets a worrying precedent for UK stock market
  • a pipette drips fluid into a line of test tubes with the AstraZeneca’s logo in the background

    AstraZeneca to upgrade US listing in ‘knock-back for London’

    UK’s biggest drugmaker will put its US shares on a par with its London-based stock but says HQ will stay in Cambridge

    • UK set on resolving standoff with big pharma, science minister says

    • The Guardian view on Merck’s exit: Britain’s biopharma strategy stalls in the face of China’s rise

    • AstraZeneca pauses £200m investment in Cambridge research site

August 2025

  • Bayer office in Berlin, Germany.

    Shares in European drug companies hit four-month low as Trump tariffs loom

    President repeats threat to bring in levies ‘within next week or so’ in attempt to get companies to move production to US

July 2025

  • Nils Pratley

    Nils Pratley on finance
    Ministers take note: now is the moment to fight to keep AstraZeneca’s listing in London

    Nils Pratley
  • Pascal Soriot pictured in front of US flags

    AstraZeneca chief executive hails ‘vital importance of US’ as Trump tariffs loom

  • Screen grab of Andrew Bailey, governor at the Bank of England, appearing before the Treasury Committee today

    Business live
    Rachel Reeves vows to stick to fiscal rules and declines to rule out wealth tax – as it happened

  • AstraZeneca CEO Pascal Soriot speaks during an event with Virginia governor Glenn Youngkin to announce the investment in US manufacturing

    AstraZeneca to invest $50bn in US by 2030 amid Trump tariff threats

  • If AstraZeneca goes to the US, it will be a major blow for London and Labour

  • AstraZeneca boss ‘wants to shift stock market listing to US’

April 2025

  • Capsules sit in a sample container at an AstraZeneca factory in Sweden

    Drugmaker AstraZeneca shifts more production to US amid Trump tariffs

  • Pascal Soriot poses for a photo in a garden, in a suit

    Observer business agenda
    China, America and pay inject drama into AstraZeneca’s AGM

March 2025

  • Environmental Protesters Gather Outside Shell's AGM<br>LONDON, ENGLAND - MAY 21: An environmental protester is removed by security after demonstrating during the Shell annual general meeting on May 21, 2024 in London, England. The protest, organised by the Climate Justice Coalition - which includes NGOs such as Fossil Free London, War on Want, and Extinction Rebellion UK - coincides with Shell's 2024 Annual General Meeting, where shareholders vote on the company's energy transition update. (Photo by Carl Court/Getty Images)

    Observer business agenda
    It’s AGM time, season of free sandwiches and protest fireworks

  • An exterior of an AstraZeneca office with the logo on the outside of the building

    AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing

About 1,098 results for AstraZeneca
1234...
Explore more on these topics